Increased diagnostic testing since 2005 has followed a surge in procurement by national governments of rapid diagnostic tests (RDTs), which are immune chromatography–based assays that detect malaria antigens, such as Plasmodium falciparum– specific histidine-rich protein 2 (HRP-2) [1, 3–7]. This evidence concerns the gene HDGFL2 and malaria.